Posted on 5월 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on 3월 2, 20223/2/22
Succeed When Others Fail: Avoiding 20% in Investment Waste During Launch
Posted on 1월 28, 20221/28/22
How to Ensure Speed and Efficiency When Launching in Europe
Posted on 1월 26, 20221/26/22
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
Posted on 1월 20, 20221/20/22
A Holistic Launch in Europe Is Possible, But Change Is Necessary
Posted on 1월 11, 20221/11/22
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
Posted on 12월 22, 202112/22/21
Why Launching in Europe Is Unlike Launching Anywhere Else
Posted on 11월 9, 202111/9/21
EPP Keynote Address: Global Pricing and Market Access Hurdles for Innovation
Posted on 11월 2, 202111/2/21
Telling the Whole Story: An Integrated Approach to Value Proposition Creation
Posted on 10월 15, 202110/15/21